Investor Class Certified On Claims Pfizer Masked Drug Risks

Law360, New York (March 30, 2012, 4:52 PM EDT) -- A New York federal judge on Thursday certified a class of Pfizer Inc. investors accusing the pharmaceutical giant of securities fraud for allegedly concealing studies showing the heart attack risks linked to arthritis drugs Celebrex and Bextra.

U.S. District Judge Laura Taylor Swain said the plaintiffs, a class of investors who had bought Pfizer stock between October 2000 and October 2005, had adequately shown that there were questions of law and fact common to the class and that the class representative’s claims are typical of those...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Pfizer Securities Litigation


Case Number

1:04-cv-09866

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Laura Taylor Swain

Date Filed

December 15, 2004

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.